Therapeutic Gene Transfer to the Nervous System Using Viral Vectors

References

• Andratschke N, Grosu AL, Molls M, Nieder C (2001). Perspectives in the treatment of malignant gliomas in adults. Anticancer Res 21: 3541–3550.
   PubMed Web of Science ®Google Scholar
• Apfel SC (1999). Neurotrophic factors in peripheral neu-ropathies: therapeutic implications. Brain Pathol 9: 393–413.
   PubMed Web of Science ®Google Scholar
• Apfel SC (2001). Neurotrophic factor therapy-prospects and problems. Clin Chem Lab Med 39: 351–355.
   PubMed Web of Science ®Google Scholar
• Apfel SC (2002). Is the therapeutic application of neu-rotrophic factors dead? Ann Neurol 51: 8–11.
   PubMed Web of Science ®Google Scholar
• Bensadoun JC, Deglon N, Tseng JL, Ridet JL, Zurn AD, Aebischer P (2000). Lentiviral vectors as a gene deliv-ery system in the mouse midbrain: cellular and behav-ioral improvements in a 6-0HDA model of Parkinson's disease using GDNF. Exp Neurol 164: 15–24.
   PubMed Web of Science ®Google Scholar
• Betz AL, Yang GY, Davidson BL (1995). Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain. J Cereb Blood Flow Metab 15: 547–551.
   PubMed Web of Science ®Google Scholar
• Bilang-Bleuel A, Revah F, Colin P, Locquet I, Robert JJ, Mallet J, Horellou P (1997). Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neu-rotrophic factor prevents dopaminergic neuron degen-eration and behavioral impairment in a rat model of Parkinson disease. Proc Natl Acad Sci U S A 94: 8818–8823.
   PubMed Web of Science ®Google Scholar
• Bjorklund A, Kink D, Rosenblad C, Georgievska B, Lundberg C, Mandel RJ (2000). Towards a neuroprotec-tive gene therapy for Parkinson's disease: use of aden-ovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model. Brain Res 886: 82–98.
   PubMed Web of Science ®Google Scholar
• Blesch A, Lu P, Tuszynski MH (2002). Neurotrophic fac-tors, gene therapy, and neural stem cells for spinal cord repair. Brain Res Bull 57: 833–838.
   PubMed Web of Science ®Google Scholar
• Bordet T, Schmalbruch H, Pettmann B, Hagege A, Castelnau-Ptakhine L, Kahn A, Haase G (1999). Aden-oviral cardiotrophin-1 gene transfer protects pmn mice from progressive motor neuronopathy. J Clin Invest 104: 1077–1085.
   PubMed Web of Science ®Google Scholar
• Bosch A, Perret E, Desmaris N, Heard JM (2000a). Long-term and significant correction of brain lesions in adult mucopolysaccharidosis type VII mice using recombi-nant AAV vectors. Mo/ Ther 1: 63–70.
   PubMed Web of Science ®Google Scholar
• Bosch A, Perret E, Desmaris N, Trono D, Heard JM (2000b). Reversal of pathology in the entire brain of mucopolysaccharidosis type VII mice after lentivirus-mediated gene transfer. Hum Gene Ther 11: 1139–1150.
   Google Scholar
• Braz J, Beaufour C, Coutaux A, Epstein AL, Cesselin F, Hamon M, Pohl M (2001). Therapeutic efficacy in exper-imental polyarthritis of viral-driven enkephalin over-production in sensory neurons. J Neurosci 21: 7881–7888.
   Google Scholar
• Brooks Al, Stein CS, Hughes SM, Heth J, McCray PM Jr, Sauter SL, Johnston JC, Cory-Slechta DA, Federoff HJ, Davidson BL (2002). Functional correction of es-tablished central nervous system deficits in an animal model of lysosomal storage disease with feline immun-odeficiency virus-based vectors. Proc Nati Acad Sci USA 99: 6216–6221.
   PubMed Web of Science ®Google Scholar
• Carmen IH (2001). A death in the laboratory: the politics of the Gelsinger aftermath. Mo/ Ther 3: 425–428.
   PubMed Web of Science ®Google Scholar
• Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P, Selz F, Hue C, Certain S, Casanova JL, Bousso P, Deist FL, Fischer A (2000). Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288: 669–672.
   PubMed Web of Science ®Google Scholar
• Chattopadhyay M, Goss J, Lacomis D et al (2003). Protective effect of HSV-mediated gene transfer of nerve growth fac-tor in pyridoxine neuropathy demonstrates functional activity of trkA receptors in large sensory neurons of adult animals. Eur j Neurosci 17: 732–740.
   PubMed Web of Science ®Google Scholar
• Chattopadhyay M, Wolfe D, Huang S, Goss J, Glorioso J, Mata M, Fink D (2002). In vivo gene therapy of pyridoxine-induced neuropathy by HSV-mediated gene transfer of neurotrophin-3. Ann Neurol 51: 19–27.
   Google Scholar
• Choi-Lundberg DL, Lin Q, Schallert T, Crippens D, Davidson BL, Chang YN, Chiang YL, Qian J, Bardwaj L, Bohn MC (1998). Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector en-coding glial cell line-derived neurotrophic factor. Exp Neurol 154: 261–275.
   PubMed Web of Science ®Google Scholar
• Connor B, Kozlowski DA, Schallert T, Tillerson JL, Davidson BL, Bohn MC (1999). Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat. Gene Ther 6: 1936–1951.
   Google Scholar
• Consiglio A, Quattrini A, Martino S, Bensadoun JC, Dolcetta D, Trojani A, Benaglia G, Marchesini S, Cestari V, Oliverio A, Bordignon C, Naldini L (2001). In vivo gene therapy of metachromatic leuko dystrophy by lentiviral vectors: correction of neuropathology and pro-tection against learning impairments in affected mice. Nat Med 7: 310–316.
   Google Scholar
• During MJ, Kaplitt MG, Stern MB, Eidelberg D (2001). Sub-thalamic GAD gene transfer in Parkinson disease pa-tients who are candidates for deep brain stimulation. Hum Gene Ther 12: 1589–1591.
   Google Scholar
• During MJ, Naegele JR, O'Malley KL, Geller Al (1994). Long-term behavioral recovery in Parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science 266: 1399–1403.
   PubMed Web of Science ®Google Scholar
• Facchiano F, Fernandez E, Mancarella S, Maira G, Mis-cusi M, D'Arcangelo D, Cimino-Reale G, Falchetti ML, Capogrossi MC, Pallini R (2002). Promotion of regenera-tion of corticospinal tract axons in rats with recombinant vascular endothelial growth factor alone and combined with adenovirus coding for this factor. J Neurosurg 97: 161–168.
   PubMed Web of Science ®Google Scholar
• Finegold AA, Mannes AJ, Iadarola MJ (1999). A paracrine paradigm for in vivo gene therapy in the central nervous system: treatment of chronic pain. Hum Gene Ther 10: 1251–1257.
   Google Scholar
• Friedmann T, Roblin R (1972). Gene therapy for human genetic disease? Science 175: 949–955.
   PubMed Web of Science ®Google Scholar
• Frisella WA, O'Connor LH, Vogler CA, Roberts M, Walkley S, Levy B, Daly TM, Sands MS (2001). Intracranial in-jection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysac-charidosis type VII. Mo/ Ther 3: 351–358.
   PubMed Web of Science ®Google Scholar
• Fu H, Samulski RJ, McCown TJ, Picomell YJ, Fletcher D, Muenzer J (2002). Neurological correction of lysosomal storage in a mucopolysaccharidosis IIIB mouse model by adeno-associated virus-mediated gene delivery. Mo/ Ther 5: 42–49.
   PubMed Web of Science ®Google Scholar
• Ghodsi A, Stein C, Derksen T, Martins I, Anderson RD, Davidson BL (1999). Systemic hyperosmolality im-proves beta-glucuronidase distribution and pathology in murine MPS VII brain following intraventricular gene transfer. Exp Neurol 160: 109–116.
   PubMed Web of Science ®Google Scholar
• Goss JR, Mata M, Goins WF et al (2001). Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root gan-glion. Gene Ther 8: 551–556.
   PubMed Web of Science ®Google Scholar
• Goss JR, Goins WF, Lacomis D, Mata M, Glorioso JC, Fink DJ (2002a). Herpes simplex-mediated gene transfer of nerve growth factor protects against peripheral neruropathy in streptozotocin-induced diabetes in the mouse. Diabetes 51: 2227–2232.
   PubMed Web of Science ®Google Scholar
• Goss JR, Harley CF, Mata M et al (2002b). Herpes vector-mediated expression of proenkephalin reduces pain-related behavior in a model of bone cancer pain. Ann Neurol 52: 662–665.
   PubMed Web of Science ®Google Scholar
• Haase G, Kennel P, Pettmann B, Vigne E, Akli S, Revah F, Schmalbruch H, Kahn A (1997). Gene therapy of murine motor neuron disease using adenoviral vectors for neu-rotrophic factors. Nat Med 3: 429–436.
   PubMed Web of Science ®Google Scholar
• Hoehn B, Ringer TM, Xu L, Giffard RG, Sapolsky RM, Steinberg GK, Yenari MA (2001). Overexpression of H5P72 after induction of experimental stroke protects neurons from ischemic damage. J Cereb Blood Flow Metab 21: 1303–1309.
   PubMed Web of Science ®Google Scholar
• Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfaff DW, O'Malley KL, During MJ (1994). Long-term gene expres-sion and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 8: 148–154.
   PubMed Web of Science ®Google Scholar
• Keir SD, Xiao X, Li J, Kennedy PG (2001). Adeno-associated virus-mediated delivery of glial cell line-derived neu-rotrophic factor protects motor neuron-like cells from apoptosis. J NeuroVirol 7: 437–446.
   Google Scholar
• Kennedy PG (1997). Potential use of herpes simplex virus (HSV) vectors for gene therapy of neurological disorders. Brain 120 ( Pt 7): 1245–1259.
   Google Scholar
• Kordower JH, Emborg ME, Bloch J, Ma SY, Chu Y, Leventhal L, McBride J, Chen EY, Palfi S, Roitberg BZ, Brown WD, Holden JE, Pyzalski R, Taylor MD, Garvey P, Ling Z, Trono D, Hantraye P, Deglon N, Aebischer P (2000). Neurodegeneration prevented by lentiviral vec-tor delivery of GDNF in primate models of Parkinson's disease. Science 290: 767–773.
   PubMed Web of Science ®Google Scholar
• Lawrence MS, McLaughlin JR, Sun GH, Ho DY, McIntosh L, Kunis DM, Sapolsky RM, Steinberg GK (1997). Herpes simplex viral vectors expressing Bc1-2 are neuroprotec-tive when delivered after a stroke. J Cereb Blood Flow Metab 17: 740–744.
   PubMed Web of Science ®Google Scholar
• Leone P, Janson CG, Bilaniuk L, Wang Z, Sorgi F, Huang L, Matalon R, Kaul R, Zeng Z, Freese A, McPhee SW, Mee E, During MJ, Bilianuk L (2000). Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan disease. Ann Neurol 48: 27–38.
   Google Scholar
• Mandel RJ, Snyder RO, Leff SE (1999). Recombinant adeno-associated viral vector-mediated glial cell line-derived neurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degenera-tion in a rat model of Parkinson's disease. Exp Neurol 160: 205–214.
   PubMed Web of Science ®Google Scholar
• Mandel RJ, Spratt SK, Snyder RO, Leff SE (1997). Midbrain injection of recombinant adeno-associatedvirus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats. Proc Natl Acad Sci U S A 94: 14083–14088.
   PubMed Web of Science ®Google Scholar
• Markert JM, Parker JN, Gillespie GY, Whitley RJ (2001). Ge-netically engineered human herpes simplex virus in the treatment of brain tumours. Herpes 8: 17–22.
   PubMedGoogle Scholar
• Mata M, Zhang M, Hu X, Fink DJ (2001). HveC (nectin-1) is expressed at high levels in sensory neurons, but not in motor neurons, of the rat peripheral nervous system. J NeuroVirol 7: 476–480.
   PubMed Web of Science ®Google Scholar
• Natsume A, Mata M, Wolfe D, Oligino T, Goss J, Huang S, Glorioso J, Fink DJ (2002). Bc1-2 and GDNF delivered by HSV-mediated gene transfer after spinal root avul-sion provide a synergistic effect. J Neurotrauma 19: 61–68.
   Google Scholar
• Ohashi T, Watabe K, Uehara K, Sly WS, Vogler C, Eto Y (1997). Adenovirus-mediated gene transfer and ex-pression of human beta-glucuronidase gene in the liver, spleen, and central nervous system in mucopolysaccha-ridosis type VII mice. Proc Natl Acad Sci USA 94: 1287–1292.
   PubMed Web of Science ®Google Scholar
• Peltola M, Kyttala A, Heinonen 0, Rapola J, Paunio T, Revah F, Peltonen L, Jalanko A (1998). Adenovirus-mediated gene transfer results in decreased lysosomal storage in brain and total correction in liver of as-partylglucosaminuria (AGU) mouse. Gene Ther 5: 1314–1321.
   Google Scholar
• Romero MI, Rangappa N, Garry MG, Smith GM (2001). Functional regeneration of chronically injured sensory afferents into adult spinal cord after neurotrophin gene therapy. J Neurosci 21: 8408–8416.
   PubMedGoogle Scholar
• Sanchez-Pemaute R, Harvey-White J, Cunningham J, Bankiewicz KS (2001). Functional effect of adeno-associated virus mediated gene transfer of aromatic t-amino acid decarboxylase into the striatum of 6-0HDA-lesioned rats. Mo/ Ther 4: 324–330.
   Google Scholar
• Schratzberger P, Schratzberger G, Silver M, Curry C, Kearney M, Magner M, Alroy J, Adelman LS, Weinberg DH, Ropper AH, Isner JM (2000). Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy. Nat Med 6: 405–413.
   PubMed Web of Science ®Google Scholar
• Schratzberger P, Walter DH, Rittig K, Bahlmann FH, Pola R, Curry C, Silver M, Krainin JG, Weinberg DH, Ropper AH, Isner JM (2001). Reversal of experimental diabetic neuropathy by VEGF gene transfer. J Clin Invest 107: 1083–1092.
   PubMed Web of Science ®Google Scholar
• Sferra TJ, Qu G, McNeely D, Rennard R, Clark KR, Lo WD, Johnson PR (2000). Recombinant adeno-associated virus-mediated correction of lysosomal stor-age within the central nervous system of the adult mu-copolysaccharidosis type VII mouse. Hum Gene Ther 11: 507–519.
   Google Scholar
• Shibata M, Murray M, Tessler A, Ljubetic C, Connors T, Saavedra RA (2000). Single injections of a DNA plasmid that contains the human Bc1-2 gene prevent loss and at-rophy of distinct neuronal populations after spinal cord injury in adult rats. Neurorehabil Neural Repair 14: 319–330.
   Google Scholar
• Shimazaki K, Urabe M, Monahan J, Ozawa K, Kawai N (2000). Adeno-associated virus vector-mediated bc1-2 gene transfer into post-ischemic gerbil brain in vivo: prospects for gene therapy of ischemia-induced neu-ronal death. Gene Ther 7: 1244–1249.
   Google Scholar
• Skorupa AF, Fisher KJ, Wilson JM, Parente MK, Wolfe JH (1999). Sustained production of beta-glucuronidase from localized sites after AAV vector gene transfer re-sults in widespread distribution of enzyme and reversal of lysosomal storage lesions in a large volume of brain in mucopolysaccharidosis VII mice. Exp Neurol 160: 17–27.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Schwarz E, Ljubetic C, Murray M, Tessler A, Saavedra RA (1999). DNA plasmid that codes for human Bc1-2 gene preserves axotomized Clarke's nucleus neu-rons and reduces atrophy after spinal cord hemisection in adult rats. J Comp Neurol 404: 159–171.
   Google Scholar
• Tsai TH, Chen SL, Chiang YH, Lin SZ, Ma HI, Kuo SW, Tsao YP (2000). Recombinant adeno-associated virus vector expressing glial cell line-derived neurotrophic factor re-duces ischemia-induced damage. Exp Neurol 166: 266–275.
   PubMed Web of Science ®Google Scholar
• Tuszynski MH (1997). Gene therapy for nervous system disease. Ann NY Acad Sci 835: 1–11.
   Google Scholar
• Wilson SP, Yeomans DC, Bender MA, Lu Y, Goins WF, Glorioso JC (1999). Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus. Proc Nati Acad Sci US A 96: 3211–3216.
   PubMed Web of Science ®Google Scholar
• Yamada M, Natsume A, Mata M, Oligino T, Goss J, Glorioso J, Fink DJ (2001). Herpes simplex virus vector-mediated expression of Bc1-2 protects spinal motor neurons from degeneration following root avulsion. Exp Neurol 168: 225–230.
   Google Scholar
• Yamada M, Oligino T, Mata M, Goss JR, Glorioso JC, Fink DJ (1999). Herpes simplex virus vector-mediated expres-sion of Bc1-2 prevents 6-hydroxydopamine-induced de-generation of neurons in the substantia nigra in vivo. Proc Nati Acad Sci US A 96: 4078–4083.
   Google Scholar
• Zhang Y, Dijkhuizen PA, Anderson PN, Lieberman AR, Verhaagen J (1998). NT-3 delivered by an adenoviral vector induces injured dorsal root axons to regenerate into the spinal cord of adult rats. J Neurosci Res 54: 554–562.
   PubMed Web of Science ®Google Scholar